U.S. Markets open in 8 hrs 41 mins

Gilead Sciences, Inc. (GILD)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
72.60+0.49 (+0.68%)
At close: 4:00PM EDT
People also watch
CELGBIIBAMGNBMYREGN
Full screen
Previous Close72.11
Open72.08
Bid0.00 x 0
Ask0.00 x 0
Day's Range72.08 - 72.96
52 Week Range63.76 - 82.10
Volume5,531,782
Avg. Volume8,774,180
Market Cap94.82B
Beta1.08
PE Ratio (TTM)7.67
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (2.88%)
Ex-Dividend Date2017-09-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • 3 Value Stocks for Smart Investors
    Motley Fool5 hours ago

    3 Value Stocks for Smart Investors

    There's still plenty of value to be found in this overheated market from the likes of Gilead Sciences, IBM, and Ambarella.

  • Barrons.com10 hours ago

    Gilead: Where's the Urgency?

    Gilead Sciences (GILD) has gained 13% during the past three months as investors have started to bet that the beaten-down biotech stock has finally found a bottom. The iShares Nasdaq Biotechnology ETF (IBB) has dipped 0.1% to $303.67.

  • Mylan Finalizes Settlement Agreement with DOJ for $465M
    Zacks3 days ago

    Mylan Finalizes Settlement Agreement with DOJ for $465M

    Mylan N.V. (MYL) signed an agreement with the U.S. Department of Justice (DOJ) and two other relators to finalize the Medicaid drug rebate settlement worth $465 million, announced in Oct 2017.